Antibody Enzyme Conjugate

A company called Palaeon Pharmaceuticals is working on a drug candidate for cancer patients. They re-engineered the antibody enzyme conjugate so that it could be made entirely by a cell. The Caleon just had what's called an investigational new drug application approved at the FDA. That means they've been given a green light to start testing their first immune therapy candidate in human cancer patients.